Ask-the-Expert Online Conference
- Question from Joan: Is Femara after tamoxifen really the new miracle to help prevent the cancer from coming back after five years of tamoxifen?
- Answers - Lynn Hartmann Femara does help to further reduce the risk of recurrence of breast cancer after tamoxifen. For every woman's situation, we must determine how great her risk of recurrence is after tamoxifen and whether or not there is significant justification for the Femara. In one example, if a woman had only a 10% risk of recurrence after tamoxifen, the Femara might provide only two or three percentage points lower risk, in which case the side effects she experienced could outweigh the benefit. So it is judged on a case-by-case basis, and it depends on the women's risk of recurrence whether we recommend Femara after five years of tamoxifen.
This Ask-the-Expert Online Conference called Risk Reduction featured Beth Baughman DuPree, M.D., F.A.C.S. and Lynn Hartmann answering your questions about breast cancer risk factors and ways to lower your risk.
Editor's Note: This conference took place in February 2006.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.